NICE will be making two announcements on cancer treatments this week. Preliminary recommendations is published for consultation today (24 November) state that the use of bevacizumab for the treatment of metastatic colorectal cancer does not represent a cost-effective use of NHS resources.
Link:http://www.medicalnewstoday.com/articles/172121.php
Source:Medical News Today